Change in screening programme could come as result of dramatic reductions in cervical cancer
The HPV vaccine is leading to such dramatic reductions in cervical cancer that those who receive it may only need one smear test in their lives, according to a leading cancer prevention scientist.
The academic director of King’s Clinical Trials Unit, Prof Peter Sasieni, said the screening programme – which currently needs to be performed every three to five years – could soon change due to the encouraging results from the new HPV vaccine.
